October is Liver Cancer Awareness Month, a time to recognize and support the more than 41,000 people in the US who are diagnosed with liver cancer each year,1 and highlight the important strides being made to reimagine what’s possible for this patient community.
More than half of patients with hepatocellular carcinoma (HCC), the most common type of liver cancer, 2 are not diagnosed until advanced stages, putting their five-year survival rate at only 7%. 3 Through our invaluable partnerships with patient advocacy organizations like the American Liver Foundation, we know firsthand that people living with liver cancer and their loved ones want and deserve more — more hope, more research, and importantly, more time.
Now, patients diagnosed with advanced HCC and their loved ones have reason to believe in the possibility of more time. This era of renewed “possibility” for patients is echoed by Lorraine Stiehl, CEO of the American Liver Foundation. Take a listen as she describes how progress in research and medical innovation is reimagining patient expectations around survival, ultimately creating a meaningful impact on the lives of people affected by this challenging disease.
References
- American Cancer Society. Key statistics about liver cancer. Accessed October 2024. Available at https://www.cancer.org/cancer/types/liver-cancer/about/what-is-key-statistics.html
- National Cancer Institute. Liver cancer causes, risk factors, and prevention. Accessed October 2024. Available at www.cancer.gov/types/liver/what-is-liver-cancer/causes-risk-factor
- Sayiner M, Golabi P, Younossi ZM. Disease burden of hepatocellular carcinoma: A global perspective. Dig Dis Sci. 2019;64(4):9 10-917.